FASLG and cardiovascular disorder: In summary, platelets from patients with disease did not have higher PE/PS externalization or elevated thrombin generation capacity, suggesting that changes in platelet aPL do not significantly contribute to the higher thrombotic risk seen in cardiovascular disease.